Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Race to Publish Shows Glaxo Zeal to Get Leg Up in China
Bloomberg
Thursday, August 8, 2013 - 8:13am
tags:
GSK, China
Sales of Ariad's cancer drug Iclusig top estimates
Yahoo/AP
Thursday, August 8, 2013 - 8:12am
tags:
Ariad Pharmaceuticals, Iclusig, earnings
The Deal: Vivus Considers Next Steps With Big Pharma Partners
TheStreet.com
Wednesday, August 7, 2013 - 4:08pm
tags:
Vivus, Qsymia, Belviq
Pfizer to Pay $1.8 Million in Prempro Punitive Damages
Bloomberg
Wednesday, August 7, 2013 - 4:05pm
tags:
Pfizer, Prempro
Arena And Vivus - Looking At Prescriptions
Seeking Alpha
Wednesday, August 7, 2013 - 12:41pm
tags:
Vivus, Arena Pharmaceuticals, Qsymia, Belviq, obesity, prescription data
Rigel Pharma Narrows Q2 Loss
Yahoo/AP
Wednesday, August 7, 2013 - 12:40pm
tags:
earnings, Rigel Pharmaceuticals
Stada in 'exclusive talks' to buy British OTC drugmaker
Fierce Pharma
Wednesday, August 7, 2013 - 10:21am
tags:
Stada, OTC, M&A, Thornton & Ross
Lundbeck recruiting 200-plus sales reps for Brintellix launch
Fierce Pharma
Wednesday, August 7, 2013 - 10:19am
tags:
hirings, Lundbeck, antidepressants, drug launches, Brintellix
Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
Motley Fool
Wednesday, August 7, 2013 - 10:14am
tags:
Isis Pharmaceuticals, ISIS-CRPRx
Jazz Pharma Earnings Miss, But Guidance Bullish
Investors.com
Wednesday, August 7, 2013 - 10:11am
tags:
earnings, Jazz Pharmaceuticals
Tax benefit, higher sales lift Santarus 2Q profit
Yahoo/AP
Wednesday, August 7, 2013 - 10:10am
tags:
earnings, Santarus
More Trouble For Vanda's Sleep Disorder Drug
TheStreet.com
Wednesday, August 7, 2013 - 9:47am
tags:
Vanda, tasimelteon, non-24 hour disorder
Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Yahoo
Wednesday, August 7, 2013 - 9:45am
tags:
earnings, Orexigen
3 Companies Working to Make Migraines Milder
Motley Fool
Wednesday, August 7, 2013 - 9:36am
tags:
migraines, Allergan, Botox, LY2951742, Eli Lilly, Arteaus Therapeutics, Merck, MK-1602, Alder Biopharmaceuticals, ALD403, Bristol-Myers Squibb
Endo 2Q net income rises as charges decrease
Yahoo/AP
Wednesday, August 7, 2013 - 9:25am
tags:
earnings, Endo Health Solutions
Is The FDA Being Compromised By Pharma Payments?
Forbes
Wednesday, August 7, 2013 - 9:24am
tags:
FDA, drug approvals
New Vivus CEO to focus on retail push for diet pill
Reuters
Wednesday, August 7, 2013 - 9:22am
tags:
Vivus, obesity, Anthony Zook, Qsymia, earnings
Abbott agrees to pay $12 mn fine in China price fixing probe
Economic Times, India
Wednesday, August 7, 2013 - 9:21am
tags:
Abbott Labs, China, infant formula
Novartis drug shows no survival benefit in liver cancer
Chicago Tribune, IL
Wednesday, August 7, 2013 - 9:15am
tags:
liver cancer, Novartis, Afinitor
Amgen Said to Boost Onyx Pharmaceuticals Bid to $130 a Share
Bloomberg
Wednesday, August 7, 2013 - 9:14am
tags:
Amgen, ONYX Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.